2015
DOI: 10.1016/j.schres.2014.10.051
|View full text |Cite
|
Sign up to set email alerts
|

Olfactory identification deficits at identification as ultra-high risk for psychosis are associated with poor functional outcome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
17
0
4

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(23 citation statements)
references
References 43 publications
2
17
0
4
Order By: Relevance
“…Our findings of more severe impairment in odor identification in bipolar patients with psychosis vs those without, coupled with greater impairment for hedonically pleasant versus unpleasant/neutral odors, directly mirror what has previously been reported both for schizophrenia patients and clinical high‐risk youth . While initial high‐risk studies suggested that olfactory impairments might be specific predictors of actual conversion to schizophrenia, more recent data suggest that this is an index of poor functional outcome which may include overt psychosis, but which is an ominous marker of neurodevelopmental aberration independent of future diagnosis. Thus, our results are consistent with and reinforce the hypothesis that embryonic insults early in fetal development, which can give rise to both structural and behavioral olfactory anomalies, result in a heightened, but not inevitable, risk for both psychosis and overall functional impairment.…”
Section: Discussionsupporting
confidence: 85%
“…Our findings of more severe impairment in odor identification in bipolar patients with psychosis vs those without, coupled with greater impairment for hedonically pleasant versus unpleasant/neutral odors, directly mirror what has previously been reported both for schizophrenia patients and clinical high‐risk youth . While initial high‐risk studies suggested that olfactory impairments might be specific predictors of actual conversion to schizophrenia, more recent data suggest that this is an index of poor functional outcome which may include overt psychosis, but which is an ominous marker of neurodevelopmental aberration independent of future diagnosis. Thus, our results are consistent with and reinforce the hypothesis that embryonic insults early in fetal development, which can give rise to both structural and behavioral olfactory anomalies, result in a heightened, but not inevitable, risk for both psychosis and overall functional impairment.…”
Section: Discussionsupporting
confidence: 85%
“…Importantly, olfactory deficits have also been identified as indicators of several neurologic diseases, including multiple sclerosis, epilepsy, and possibly, Alzheimer’s and Parkinson’s disease 16 , 17 . They also represent ultra-high risk indicators for psychosis 18 . Very recently, olfactory dysfunction has been identified as the best predictor for 5-year mortality in older adults 19 ; outperforming such factors as heart failure, stroke, diabetes, hypertension, liver damage and even cancer 20 .…”
Section: Introductionmentioning
confidence: 99%
“…identification potentially more related to other cognitive domains, while discrimination may be a “purer” olfactory task. Together with evidence for the prognostic utility of olfactory functioning in idiopathic clinical risk and early psychosis (Brewer et al, 2003; Good et al, 2006; Lin et al, 2015; Woodberry et al, 2010), olfactory functioning is promising in its clinical relevance to psychosis in 22q11DS.…”
Section: Discussionmentioning
confidence: 99%
“…-Odor interpretation was correlated with positive symptoms (Kästner et al, 2013). Furthermore, two studies reported that in individuals at clinical risk for psychosis, odor identification deficits were predictive of later transition to a psychotic disorder (Brewer et al, 2003; Woodberry et al, 2010), while they were predictive of functional outcome (but not conversion) in another study (Lin et al, 2015). In first-episode psychosis, odor identification deficits predicted [non-remission] of symptoms after one year (Good et al, 2006).…”
Section: Introductionmentioning
confidence: 99%